Vitality Watch

Dossier pubmed review 21-sep-2026
Narrative review or expert overview without new data

A two-step model of age-associated autoreactivity: B cell-intrinsic aging meets inflammaging.

Key claim: Aging progressively relaxes B cell-intrinsic central and peripheral tolerance, and inflammaging then selectively expands inflammation-adapted autoreactive B-cell subsets (including ABCs/DN2), linking immune senescence to autoimmunity.

Abstract

Aging is associated with declining protective immunity and increased autoreactivity, yet the mechanisms linking these processes remain incompletely understood. B lymphocytes are central to this paradox because they integrate antigen recognition, innate signaling, and differentiation under tightly regulated tolerance checkpoints. This review advances the hypothesis that aging appears to drive a progressive, B cell-intrinsic relaxation of central and peripheral tolerance, leading to the accumulation of autoreactive clones. These defects are reinforced by transcriptional, epigenetic, metabolic, and signaling remodeling that durably reshapes B-cell responsiveness. In parallel, chronic low-grade inflammation (inflammaging) acts as a selective pressure that preferentially expands inflammation-adapted B-cell subsets, including age-associated B cells (ABCs) and related DN2 populations, rather than uniformly activating the B-cell compartment. This synergy promotes extrafollicular differentiation while bypassing key germinal-center tolerance checkpoints, thereby enriching for autoreactive B-cell states. A unifying model is proposed in which intrinsic aging establishes susceptibility, whereas inflammaging amplifies pathogenic B-cell programs, linking immune senescence to autoimmunity and highlighting potential targets for selective therapeutic intervention.

Why this matters

Age-related autoimmunity has usually been narrated either as generic inflammaging or as adaptive-immune exhaustion; this review pins it on a specific interaction between B cell-intrinsic tolerance breakdown and inflammation-driven expansion of ABC/DN2 subsets. It gives the vault a named B-cell node connecting immunosenescence to autoimmune disease risk, and a concrete cell population (ABCs/DN2) that any future intervention claiming to modulate immune aging would need to move. As a hypothesis synthesis it is conceptual scaffolding rather than causal evidence, and no anti-ABC intervention has shown geroprotective or autoimmunity-modifying effects in humans.

Source

Link

Briefing card

A two-step model of age-associated autoreactivity: B cell-intrinsic aging meets inflammaging.
Stage: review · pubmed · 21-sep-2026

If you are tracking immune aging as a driver of late-life autoimmune risk, this review argues the relevant cell population to watch is age-associated B cells (ABCs/DN2), not just T-cell or cytokine markers.

Aging progressively relaxes B cell-intrinsic central and peripheral tolerance, and inflammaging then selectively expands inflammation-adapted autoreactive B-cell subsets (including ABCs/DN2), linking immune senescence to autoimmunity.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11357-026-02557-5

build build 880 · 2bcef25 · 2026-11-18